Schrödinger, Inc. (NASDAQ:SDGR) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. grew its position in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 1.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,776,631 shares of the company’s stock after purchasing an additional 77,830 shares during the period. Vanguard Group Inc. owned 9.37% of Schrödinger worth $242,603,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Greenwood Capital Associates LLC increased its stake in Schrödinger by 26.4% in the fourth quarter. Greenwood Capital Associates LLC now owns 24,492 shares of the company’s stock valued at $877,000 after purchasing an additional 5,118 shares during the last quarter. Cim Investment Management Inc. acquired a new position in shares of Schrödinger during the 4th quarter valued at about $206,000. Parkman Healthcare Partners LLC lifted its holdings in shares of Schrödinger by 9.9% during the 4th quarter. Parkman Healthcare Partners LLC now owns 405,232 shares of the company’s stock worth $14,507,000 after acquiring an additional 36,578 shares during the period. Iron Triangle Partners LP acquired a new stake in shares of Schrödinger in the fourth quarter worth approximately $16,775,000. Finally, Lighthouse Investment Partners LLC purchased a new stake in Schrödinger in the fourth quarter valued at approximately $982,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on SDGR. Craig Hallum cut their price target on shares of Schrödinger from $35.00 to $30.00 and set a “buy” rating on the stock in a research note on Thursday, May 2nd. Citigroup lowered their price target on Schrödinger from $39.00 to $37.00 and set a “buy” rating for the company in a research report on Thursday, May 2nd. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, Schrödinger currently has a consensus rating of “Moderate Buy” and a consensus price target of $40.89.

Schrödinger Price Performance

NASDAQ:SDGR opened at $18.76 on Tuesday. Schrödinger, Inc. has a 12 month low of $18.21 and a 12 month high of $59.24. The business’s 50-day moving average is $21.94 and its two-hundred day moving average is $26.29. The firm has a market capitalization of $1.36 billion, a PE ratio of -9.98 and a beta of 1.53.

Schrödinger (NASDAQ:SDGR) last released its quarterly earnings results on Wednesday, May 1st. The company reported ($0.76) EPS for the quarter, hitting the consensus estimate of ($0.76). The firm had revenue of $36.60 million for the quarter, compared to analyst estimates of $41.23 million. Schrödinger had a negative return on equity of 29.25% and a negative net margin of 75.94%. Equities analysts anticipate that Schrödinger, Inc. will post -2.7 EPS for the current year.

Schrödinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.